Zonisamide Capsule
FDA Label NDC 70771-1142

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Zonisamide (NDC 70771-1142). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1142-1 in bottle of 100 Capsules

Zonisamide Capsules, 25 mg

Rx only

100 Capsules

Zonisamide Capsules, 25 mg (1442d938 61eb 438e B5be 900bda532050 01)

Zonisamide Capsules, 25 mg (1442d938 61eb 438e B5be 900bda532050 01)

NDC 70771-1143-1 in bottle of 100 Capsules

Zonisamide Capsules, 50 mg

Rx only

100 Capsules

Zonisamide Capsules, 50 mg (1442d938 61eb 438e B5be 900bda532050 02)

Zonisamide Capsules, 50 mg (1442d938 61eb 438e B5be 900bda532050 02)

NDC 70771-1144-1 in bottle of 100 Capsules

Zonisamide Capsules, 100 mg

Rx only

100 Capsules

Zonisamide Capsules, 100 mg (1442d938 61eb 438e B5be 900bda532050 03)

Zonisamide Capsules, 100 mg (1442d938 61eb 438e B5be 900bda532050 03)

* Please review the disclaimer below.